Call Boomerang Books 1300 36 33 32

Get Latest Book News + FREE Shipping. Subscribe to the Boomerang Books Bulletin eNewsletter right now!

Description - Nuclear Receptors as Drug Targets by Eckhard Ottow

Edited by two experts working at the pioneering pharmaceutical company and major global player in hormone-derived drugs, this handbook and reference systematically treats the drug development aspects of all human nuclear receptors, including recently characterized receptors such as PPAR, FXR and LXR. Authors from leading pharmaceutical companies around the world present examples and real-life data from their own work.

Buy Nuclear Receptors as Drug Targets by Eckhard Ottow from Australia's Online Independent Bookstore, Boomerang Books.

Book Details

ISBN: 9783527318728
ISBN-10: 3527318720
Format: Hardback
(248mm x 179mm x 31mm)
Pages: 522
Imprint: Wiley-VCH Verlag GmbH
Publisher: Wiley-VCH Verlag GmbH
Publish Date: 20-Aug-2008
Country of Publication: Germany

Book Reviews - Nuclear Receptors as Drug Targets by Eckhard Ottow

» Have you read this book? We'd like to know what you think about it - write a review about Nuclear Receptors as Drug Targets book by Eckhard Ottow and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a Boomerang Books Account Holder - it's free to sign up and there are great benefits!)

Write Review


Author Biography - Eckhard Ottow

Eckard Ottow is the head of medicinal chemistry at Schering AG in Berlin (Germany). He studied Chemistry at the University of Hannover (Germany) and received his PhD degree in 1982. He joined Schering AG in 1983, first in the field of endocrinology and later in oncology and CNS. In 2002, he was appointed to his present position as head of medicinal chemistry. He is also a honorary professor at the Technical University of Berlin. Hilmar Weinmann studied Chemistry at the universities of Tubingen and Hannover (Germany). He joined Schering in 1995, where he is currently a department head of Medicinal Chemistry. His main fields of expertise are in oncology, dermatology and gender healthcare.